Corporate News 02-Feb-24
Board of Dr. Lal PathLabs recommends second interim dividend
Of Rs 12 per share
Dr. Lal PathLabs announced that the Board of Directors of the Company at its meeting held on 1 February 2024, inter alia, have recommended the second interim dividend of Rs 12 per equity Share (i.e. 120%) , subject to the approval of the shareholders.
Previous News
Dr Lal Pathlabs
( Results - Analysis 02-Feb-23 18:25 )
Dr Lal PathLabs spurts as Q2 PAT climbs 53% YoY To Rs 111 cr
( Hot Pursuit - 02-Nov-23 17:19 )
Dr. Lal PathLabs to hold AGM
( Corporate News - 29-Jul-23 12:52 )
Astrazeneca Pharma India Ltd leads gainers in 'A' group
( Hot Pursuit - 27-May-22 12:00 )
Dr Lal PathLab corrects after four-day rally
( Hot Pursuit - 30-Nov-21 09:56 )
Dr Lal Pathlabs standalone net profit declines 23.26% in the March 2020 quarter
( Results - Announcements 18-May-20 14:40 )
Dr Lal Pathlabs consolidated net profit declines 31.00% in the March 2020 quarter
( Results - Announcements 18-May-20 14:48 )
Lal PathLabs slips after Q3 PAT falls nearly 8% YoY; EBITDA at Rs 122 crore
( Hot Pursuit - 02-Feb-23 16:26 )
Dr. Lal PathLabs to hold board meeting
( Corporate News - 25-Jan-23 12:26 )
Dr Lal Pathlabs
( Results - Analysis 28-Jul-23 11:08 )
Dr Lal Pathlabs Ltd Falls 3.18%
( Hot Pursuit - 30-Nov-21 09:45 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top